Boston, MA 03/27/2014 (wallstreetpr) – Alimera Sciences Inc (NASDAQ:ALIM) was last seen hitting on the positive side of things. Shares of the biopharma company jumped 0.29 percent to $6.98 in the regular session, a move that was carried all the way into the post-market session. The Wednesday session placed the stock among the day movers, turning above average volume of shares in the range of $6.95 – $7.49, having opened at $7. In the past one-year as of the previous session, shares of Alimera Sciences Inc (NASDAQ:ALIM) changed hands between $1.65 low and $8.44 high.
Insider buying activity in Rentrak Corporation (NASDAQ:RENT) helped shares of the company to jump during trading Wednesday. The shares rose 4.78 percent to settle at $61.87 after news emerged that CEO William Paul Livek engaged his own money to acquire 3,000 shares of the company on Tuesday. The top executive purchased a share at an average price of $57, and ended up spending $171,000 in the transaction. The acquisition boosted the amount of shares which the CEO now owns directly in the company to $170,973, bearing estimated value of $9.7 million. Insider buying is taken positively by investors as it suggests that those who better understands the company have enough faith about the direction that the business is taking. Currently the stock of Rentrak Corporation (NASDAQ:RENT) is rated buy in consensus view of analysts. The stock carries average price objective of $63.35.
Bio-Reference Laboratories Inc (NASDAQ:BRLI) was among the more than 20 healthcare organizations and companies presented Wednesday during the Healthcare Innovations Expo 2014 in Washington, D.C. The event which included showcasing of newest products and technologies in the healthcare sector, also witnessed presentation of awards. The key recognitions at the March 26, event was the Champion of Healthcare Innovations honor to U.S. Rep, Tom Reed. Notable names in the healthcare industry presenting alongside Bio-Reference Laboratories Inc (NASDAQ:BRLI) were Merck, Johnson & Johnson and Edward Lifesciences, just to identify a few. Shares of BRLI jumped 3.63 percent to $28.26 during trading Wednesday, a day that saw far bigger volume of shares changing hands.
